FolioLantern
ELEstée Lauder · Insider ownership research

Estée Lauder insiders sold $264M in the past 12 months. How much of their stake is that?

About 0.7% overall. As a group they still hold 99.5% of their starting shares. These figures leave out Ronald Lauder, the largest holder (holdings couldn't be fully reconciled).

Updated Oct 8, 2026 from SEC filings · covers Oct 9, 2025 to Oct 8, 2026
How this comparesMore of their stake sold than at 40 of the 156 other companies we can measure (#117 of 157)See ranking
0
buyers among officers and directors, past 12 months
0%
of sales were under disclosed trading plans, past 12 months
6 of 21
officers and directors sold shares, past 12 months
Recent activity · past 30 days, Sep 9, 2026 to Oct 8, 2026
Sep 14, 2026Paul Fribourg sold 58K shares ($5.7M) with no plan disclosed. That is 12% of the total stake held that day.
WhoSharesPrice% of total stakeTotal stake afterTrade dateFiled
Paul Fribourg
Director
58,000$98.1712%421KSep 14, 2026Sep 15, 2026

"% of total stake" is the shares in this event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings don't reconcile, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Sep 11, 2026Paul Fribourg sold 45K shares ($4.4M) with no plan disclosed. That is 8.6% of the total stake held that day.
WhoSharesPrice% of total stakeTotal stake afterTrade dateFiled
Paul Fribourg
Director
45,000$96.788.6%479KSep 11, 2026Sep 15, 2026

"% of total stake" is the shares in this event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings don't reconcile, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Sep 9, 2026Charlene Barshefsky sold 3.8K shares ($373K) with no plan disclosed. That is 4.5% of the total stake held that day. 4.7K shares came in from vesting or option exercises the same day, so the holding rose by 922 net.
WhoSharesPrice% of total stakeTotal stake afterTrade dateFiled
Charlene Barshefsky
Director
3,775$98.824.5%81KSep 9, 2026Sep 10, 2026

"% of total stake" is the shares in this event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings don't reconcile, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Is this normal? In line with the past 5 years. 6 insiders sold; the average is 10 a year. Year by year
Latest filing: Filed Sep 15 for a sale from Sep 11 to Sep 14. Paul Fribourg sold 103K shares ($10.0M) with no plan disclosed. Filing
116 SEC ownership filings in the period · See the evidence

What stands out

Three insiders sold $263M with no disclosed plan: Ronald Lauder ($252M), Paul Fribourg ($10.0M, 20% of holdings) and Rashida La Lande ($1.5M). The filings don't state a reason.Ronald Lauder: largest such sale, Nov 6, 2025 · Paul Fribourg: largest such sale, Sep 11, 2026 · Rashida La Lande: largest such sale, Aug 28, 2026
Outside holder Evelyn H. Lauder 2012 Marital Trust Two, a 10% owner and not part of management, sold $764M of stock.Largest sale, Nov 6, 2025
Two directors sold shares but ended with larger stakes, because more shares came in than were sold: Charlene Barshefsky (sold 3.8K, 4.7% of starting holdings; 4.7K added) and Barry Sternlicht (sold 4K, 5.6% of starting holdings; 4K added).Charlene Barshefsky: largest sale, Sep 9, 2026 · Barry Sternlicht: largest sale, Nov 11, 2025

Percentages cover 13 of 21 officers and directors. 8 are left out

i
Left out: Ronald Lauder (holdings couldn't be fully reconciled); Meridith Webster (most of their shares vested during the period, so a percentage would mislead); Jennifer Tejada (most holdings were last confirmed in 2018); Arturo Nunez, Angela Dong, Rashida La Lande, Dana Strong and Annabelle Long (held no vested shares at the start).
Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is the insider's vested stake at the start of the period (Oct 8, 2025). The gold part is what they sold.

SoldRest of starting stakeAdded during the period
Ronald Lauder
Chairman, Clinique Labs, LLC
No bar: holdings couldn't be fully reconciled.
$252MNo plan disclosed
Paul Fribourg
Director
20% · $10.0MNo plan disclosed
Rashida La Lande
Exec VP & General Counsel
No bar: held no vested shares at the start.
$1.5MNo plan disclosed
Meridith Webster
Exec VP GlobalComm/PubAffairs
No bar: most of their shares vested during the period, so a percentage would mislead.
$477KNo plan disclosed
Charlene Barshefsky
Director
Sold 4.7%, but 4.7K shares were added (mostly vesting), so the stake grew
4.7% · $373KNo plan disclosed
All 6 sellers

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesNo plan disclosed
OctNov 2025: $253M no plan disclosed$253MNovDecJanFebMarAprMayJunJulAug 2026: $1.4M no plan disclosedAugSep 2026: $10.4M no plan disclosedSepOct

Outside holders, reported separately

Evelyn H. Lauder 2012 Marital Trust Two sold $764M in the past 12 months. Large shareholders and the funds or companies that board members represent are not part of management, so they are left out of the figures above.

Details

Common questions

Is the Estée Lauder CEO selling stock?

No. Faverie de la reported no open-market sales in the past 12 months.

Why are Estée Lauder insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 0% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 100% had no disclosed plan. A trading plan schedules sales in advance.

Are any Estée Lauder insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

How much of their stake did Estée Lauder insiders sell?

About 0.7% overall. As a group they still hold 99.5% of their starting shares. These figures leave out Ronald Lauder, the largest holder (holdings couldn't be fully reconciled). That covers the 12 months to Oct 8, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold6 officers and directors: amount, % of holdings, trading plan
Who soldAmount% of holdingsTrading plan
Ronald Lauder
Chairman, Clinique Labs, LLC
$252M
2.80M shares
i
No percentage: holdings couldn't be fully reconciled.
No plan disclosed
Paul Fribourg
Director
$10.0M
103K shares
20%No plan disclosed
Rashida La Lande
Exec VP & General Counsel
$1.5M
15K shares
i
No percentage: held no vested shares at the start.
No plan disclosed
Meridith Webster
Exec VP GlobalComm/PubAffairs
$477K
5.4K shares
i
No percentage: most of their shares vested during the period, so a percentage would mislead.
No plan disclosed
Charlene Barshefsky
Director
$373K
3.8K shares
4.7%No plan disclosed
Barry Sternlicht
Director
$365K
4K shares
5.6%No plan disclosed

Outside holder, reported separately: Evelyn H. Lauder 2012 Marital Trust Two (a 10% owner, not part of management). Sold $764M (8.52M shares) from Nov 6, 2025 to Nov 6, 2025. Latest filing

The full ownership picture20 of 21 insiders fully reconciled · 16 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

InsiderHeld Oct 8, 2025SoldHeld Oct 8, 2026Still held
Ronald Lauder
!
Holdings couldn't be fully reconciled. A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +80,437,628 shares on Nov 3, 2025 (LAL Family Partners L.P). See the filing Sales and other transactions for Ronald Lauder are complete.
Chairman, Clinique Labs, LLC
n/a−2.80Mn/an/a
Vesting, gifts, unvested awards and holding lines for Ronald Lauder
+25Kshares vested or exercised
0gifted (net of own trusts)
−4Kwithheld by the company for taxes
33K → 28Kunvested awards, start → end
  • Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Holdings couldn't be fully reconciled. A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +80,437,628 shares on Nov 3, 2025 (LAL Family Partners L.P). The balances below are as reported, not verified totals.

Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock58,76358,763
children of William P. LauderClass A Common Stock10,46810,468
DirectClass B Common Stock275,010275,010
Jane A. Lauder 2003 TrustClass B Common Stock17,161,01017,161,010
Trust under Article 2 of The Zinterhofer 2008 Descendants Trust Agreement u/a/d December 24, 2008Class B Common Stock4,910,5944,910,594
Zinterhofer 2008 Descendants TrustClass B Common Stock4,910,5940
LAL Family Partners L.PClass B Common Stock069,402,943
RSL Shares TrustClass B Common Stock04,768,846
RSL 1966 TrustClass B Common Stock06,364
ALZ 2000 Revocable TrustClass B Common Stock07,708,906
4202 TrustClass B Common Stock036,961

Additional holdings last reported Feb 10, 2022, not confirmed since: 78,841,354 shares. Not included in any total or percentage on this page.

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
2,326$123.81Nov 17, 2033$0
13,752$92.87Aug 27, 2034$81K
17,427$92.87Aug 27, 2034$103K
4,094$63.90Nov 8, 2034$143K
2,780$89.92Nov 13, 2035$25K
2,780$89.92Nov 13, 2035$25K
2,780$89.92Nov 13, 2035$25K

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Eric Zinterhofer
Director
14.30M014.30Mno sales
Vesting, gifts, unvested awards and holding lines for Eric Zinterhofer
0shares vested or exercised
0gifted (net of own trusts)
1.1K → 5.1Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
SpouseClass A Common Stock1,6921,692
Spouse's TrustClass B Common Stock12,619,50012,619,500
SpouseClass B Common Stock1,675,0101,675,010

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
2,780$89.92Nov 13, 2035$25K

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Paul Fribourg
Director
524K−103K421K80%
Vesting, gifts, unvested awards and holding lines for Paul Fribourg
0shares vested or exercised
0gifted (net of own trusts)
54K → 57Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
Owned by Continental Grain CompanyClass A Common Stock520,300417,300
DirectClass A Common Stock4,0004,000

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
2,326$123.81Nov 17, 2033$0
4,094$63.90Nov 8, 2034$143K
2,780$89.92Nov 13, 2035$25K

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Charlene Barshefsky
Director
80K−3.8K81K+1.2%
Vesting, gifts, unvested awards and holding lines for Charlene Barshefsky
+4.7Kshares vested or exercised
0gifted (net of own trusts)
43K → 45Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
a family trustClass A Common Stock50,04950,971
a spousal family trustClass A Common Stock29,95029,950
SpouseClass A Common Stock5050

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
2,326$123.81Nov 17, 2033$0
4,094$63.90Nov 8, 2034$143K
2,780$89.92Nov 13, 2035$25K

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Barry Sternlicht
i
Minor difference of 17 shares. Difference is under 0.5% of holdings.
Director
71K−4K71K100%
Vesting, gifts, unvested awards and holding lines for Barry Sternlicht
+4Kshares vested or exercised
0gifted (net of own trusts)
64K → 67Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock34,79534,812
1999 Sternlicht Family Trust 1Class A Common Stock12,00012,000
1999 Sternlicht Family Trust 2Class A Common Stock12,00012,000
1999 Sternlicht Family Trust 3Class A Common Stock12,00012,000

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
2,326$123.81Nov 17, 2033$0
4,094$63.90Nov 8, 2034$143K
2,780$89.92Nov 13, 2035$25K

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Reconciliation: minor difference of 17 shares. Difference is under 0.5% of holdings.

Hudis Hertzmark
Exec VP & CBO
22K027Kno sales
Vesting, gifts, unvested awards and holding lines for Hudis Hertzmark
+11Kshares vested or exercised
0gifted (net of own trusts)
−6.1Kwithheld by the company for taxes
72K → 78Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock22,47827,385

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
27,695$92.87Aug 27, 2034$164K
78,727$91.77Aug 28, 2035$553K
61,153$106.21Aug 27, 2036$0

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Lynn Forester
Director
15K015Kno sales
Vesting, gifts, unvested awards and holding lines for Lynn Forester
0shares vested or exercised
0gifted (net of own trusts)
100K → 100Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock15,47915,479

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
2,326$123.81Nov 17, 2033$0
4,094$63.90Nov 8, 2034$143K

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Richard Zannino
i
An owner entity could not be identified from the footnotes.
Director
12K017Kno sales
Vesting, gifts, unvested awards and holding lines for Richard Zannino
+4.7Kshares vested or exercised
0gifted (net of own trusts)
13K → 14Kunvested awards, start → end
  • An owner entity could not be identified from the footnotes.
Held throughShare classOct 8, 2025Oct 8, 2026
LLCClass A Common Stock12,15916,856

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
2,326$123.81Nov 17, 2033$0
4,094$63.90Nov 8, 2034$143K
2,780$89.92Nov 13, 2035$25K

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Faverie de la
President and CEO
11K019Kno sales
Vesting, gifts, unvested awards and holding lines for Faverie de la
+15Kshares vested or exercised
0gifted (net of own trusts)
−7.3Kwithheld by the company for taxes
130K → 153Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock11,12518,630

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
23,246$92.87Aug 27, 2034$138K
23,035$75.10Feb 24, 2035$546K
176,678$91.77Aug 28, 2035$1.2M
137,238$106.21Aug 27, 2036$0

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Roberto Canevari
Exec VP & CVCO
6.8K010Kno sales
Vesting, gifts, unvested awards and holding lines for Roberto Canevari
+6.9Kshares vested or exercised
0gifted (net of own trusts)
−3.3Kwithheld by the company for taxes
36K → 38Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock6,82710,403

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
14,210$92.87Aug 27, 2034$84K
41,607$91.77Aug 28, 2035$292K
32,320$106.21Aug 27, 2036$0

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Meridith Webster
Exec VP GlobalComm/PubAffairs
3.2K−5.4K0not meaningful
Vesting, gifts, unvested awards and holding lines for Meridith Webster
+3.5Kshares vested or exercised
0gifted (net of own trusts)
−1.3Kwithheld by the company for taxes
22K → 24Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock3,1950

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
9,984$92.87Aug 27, 2034$59K
23,169$91.77Aug 28, 2035$163K
19,213$106.21Aug 27, 2036$0

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Akhil Shrivastava
Exec VP & CFO
2.4K08.1Kno sales
Vesting, gifts, unvested awards and holding lines for Akhil Shrivastava
+8.9Kshares vested or exercised
0gifted (net of own trusts)
−3.2Kwithheld by the company for taxes
38K → 50Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock2,3818,122

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
2,091$218.06Sep 3, 2030$0
1,060$344.06Sep 2, 2031$0
1,361$246.15Sep 6, 2032$0
2,027$156.39Aug 28, 2033$0
15,565$92.87Aug 27, 2034$92K
31,525$91.77Aug 28, 2035$221K
37,053$106.21Aug 27, 2036$0

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Jennifer Hyman
Director
2.4K02.4Kno sales
Vesting, gifts, unvested awards and holding lines for Jennifer Hyman
0shares vested or exercised
0gifted (net of own trusts)
3.6K → 4.4Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock2,3502,350

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
2,326$123.81Nov 17, 2033$0
4,094$63.90Nov 8, 2034$143K
2,780$89.92Nov 13, 2035$25K

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Michael Bowes
Exec VP & CPO
67501.8Kno sales
Vesting, gifts, unvested awards and holding lines for Michael Bowes
+1.7Kshares vested or exercised
0gifted (net of own trusts)
−597withheld by the company for taxes
25K → 28Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock6751,752

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
382$138.15Sep 4, 2028$0
1,022$199.49Sep 3, 2029$0
1,778$218.06Sep 3, 2030$0
1,229$344.06Sep 2, 2031$0
1,414$246.15Sep 6, 2032$0
2,030$156.39Aug 28, 2033$0
2,072$92.87Aug 27, 2034$12K
18,550$91.77Aug 28, 2035$130K
17,841$106.21Aug 27, 2036$0

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Hendrik Lammers
EVP & Cr&Io
606no sales
Vesting, gifts, unvested awards and holding lines for Hendrik Lammers
0shares vested or exercised
0gifted (net of own trusts)
0 → 38Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock66

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
28,156$111.90Feb 26, 2036$0
28,820$106.21Aug 27, 2036$0

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

Rashida La Lande
Exec VP & General Counsel
0−15K0not meaningful
Vesting, gifts, unvested awards and holding lines for Rashida La Lande
+24Kshares vested or exercised
0gifted (net of own trusts)
−8.6Kwithheld by the company for taxes
62K → 55Kunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectClass A Common Stock00

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
11,129$92.87Aug 27, 2034$66K
44,170$91.77Aug 28, 2035$310K
37,053$106.21Aug 27, 2036$0

Estimate: options held × ($98.79 − strike price), using the most recent insider trade price on Form 4 (Sep 14, 2026), not a market close.

20 of 21 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (19 exactly, 1 with a minor or footnoted difference). For 1 we show sales but not holdings; the ! icon on that row explains why. Percentages cover 13 of 21 officers and directors. Left out: Ronald Lauder (holdings couldn't be fully reconciled); Meridith Webster (most of their shares vested during the period, so a percentage would mislead); Jennifer Tejada (most holdings were last confirmed in 2018); Arturo Nunez, Angela Dong, Rashida La Lande, Dana Strong and Annabelle Long (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$264M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $264M across 2,934,991 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

No plan disclosed · $264M

Sales with no 10b5-1 plan and no tax reference in the filing. $252M of it is Ronald Lauder. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Ronald Lauder, Nov 6, 2025

Taxes

34,372 shares ($3.4M) were withheld by the company for taxes, which isn't a market sale.

SellerShares soldProceedsUnder a disclosed planShare of totalSales dates
Ronald Lauder
Chairman, Clinique Labs, LLC
2.80M$252M0%95%Nov 6, 2025 to Nov 26, 2025
Paul Fribourg
Director
103K$10.0M0%4%Sep 11, 2026 to Sep 14, 2026
Rashida La Lande
Exec VP & General Counsel
15K$1.5M0%0.6%Nov 26, 2025 to Aug 28, 2026
Meridith Webster
Exec VP GlobalComm/PubAffairs
5.4K$477K0%0.2%Nov 18, 2025 to Nov 18, 2025
Charlene Barshefsky
Director
3.8K$373K0%0.1%Sep 9, 2026 to Sep 9, 2026
Barry Sternlicht
Director
4K$365K0%0.1%Nov 11, 2025 to Nov 11, 2025

Sales by month

MonthSale proceedsDisclosed planTo cover taxesNo plan disclosed
Oct 2025$0$0$0$0
Nov 2025$253M$0$0$253M
Dec 2025$0$0$0$0
Jan 2026$0$0$0$0
Feb 2026$0$0$0$0
Mar 2026$0$0$0$0
Apr 2026$0$0$0$0
May 2026$0$0$0$0
Jun 2026$0$0$0$0
Jul 2026$0$0$0$0
Aug 2026$1.4M$0$0$1.4M
Sep 2026$10.4M$0$0$10.4M
Oct 2026$0$0$0$0
Is this normal? Selling year by year5 earlier years to compare with

In line with the past 5 years. 6 insiders sold; the average is 10 a year.

12 months endingShares soldInsiders who soldProceeds
Oct 8, 2026
Latest 12 months
2.93M6$264M
Oct 8, 2025
1 year earlier
41K5$3.4M
Oct 8, 2024
2 years earlier
54K6$6.8M
Oct 9, 2023
3 years earlier
101K6$21.9M
Oct 9, 2022
4 years earlier
3.10M13$1.02B
Oct 9, 2021
5 years earlier
7.45M18$2.07B

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty1 insider whose holdings couldn't be fully reconciled

Ronald Lauder: holdings couldn't be fully reconciled (difference of 88,311,516 shares). A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +80,437,628 shares on Nov 3, 2025 (LAL Family Partners L.P). Filing, Nov 3, 2025

Footnote: "There is no exercise or conversion price for the Class B Common Stock. Shares of Class B Common Stock may be converted immediately on a one-for-one basis by the holder and are automatically converted into Class A Common Stock on a one-for-one basis upon transfer to a person or entity that is not a "Permitted Transferee" (as defined in the Issuer's Restated Certificate of Incorporation) or soon after a record date for a meeting of stockholders where the outstanding Class B Common Stock constitutes less than 10% of the outstanding shares of Common Stock of the Issuer. | LAL Family Partners, L.P."

Barry Sternlicht: minor difference of 17 shares. Difference is under 0.5% of holdings.

Inferred rename: "LAL Family Corporation" is treated as the same holder as "LAL Family Partners L.P", because the old name was never reported again and the new one opened with the same balance (6,558,604 shares). Old name, new name

Inferred rename: "Decendents of the RSL 1996 Trust" is treated as the same holder as "Descendants of the RSL 1996 Trust", because the old name was never reported again and the new one opened with the same balance (6,364 shares). Old name, new name

Inferred rename: "FN" is treated as the same holder as "(1)", because the old name was never reported again and the new one opened with the same balance (136,796 shares). Old name, new name

Inferred rename: "Decendants of RSL 1996 Trust" is treated as the same holder as "Decendents of RSL 1966 Trust", because the old name was never reported again and the new one opened with the same balance (6,364 shares). Old name, new name

Inferred rename: "Spouse" is treated as the same holder as "Evelyn H. Lauder", because the old name was never reported again and the new one opened with the same balance (780,000 shares). Old name, new name

Inferred rename: "Zinterhofer Aerin Lauder Trust u/a/d 4/24/00" is treated as the same holder as "Aerin Lauder Zinterhofer Trust u/a/d 4/24/00", because the old name was never reported again and the new one opened with the same balance (9,865,090 shares). Old name, new name

Inferred rename: "Gary M. Lauder 2000 Revocable Trust" is treated as the same holder as "WPL GRAT, as Co-Trustee", because the old name was never reported again and the new one opened with the same balance (736,882 shares). Old name, new name

Inferred rename: "1992 GRAT f/b/o WPL" is treated as the same holder as "1992 GRAT f/b/o GML", because the old name was never reported again and the new one opened with the same balance (736,882 shares). Old name, new name

Inferred rename: "WL GRAT" is treated as the same holder as "WPL GRAT, as Co-Trustee", because the old name was never reported again and the new one opened with the same balance (3,829,216 shares). Old name, new name

Inferred rename: "GL GRAT" is treated as the same holder as "GML GRAT, as Co-Trustee", because the old name was never reported again and the new one opened with the same balance (2,687,692 shares). Old name, new name

Inferred rename: "Decendents of RSL 1966 Trust" is treated as the same holder as "Decendants or RSL 1966 Trust", because the old name was never reported again and the new one opened with the same balance (6,364 shares). Old name, new name

Inferred rename: "Trust Under Article 2 of The Zinterhofer 2008 Descendents Trust Agreement dated December 24, 2008" is treated as the same holder as "Trust under Article 2 of The Zinterhofer 2008 Descendants Trust Agreement u/a/d December 24, 2008", because the old name was never reported again and the new one opened with the same balance (4,810,594 shares). Old name, new name

Inferred rename: "1992 GRAT Remainder Trust f/b/o WPL" is treated as the same holder as "1992 GRAT Remainder Trust F/B/O William Lauder", because the old name was never reported again and the new one opened with the same balance (1,268,304 shares). Old name, new name

Inferred rename: "1992 GRAT Remainder Trust f/b/o GML" is treated as the same holder as "1992 GRAT Remainder f/b/o Gary M. Lauder", because the old name was never reported again and the new one opened with the same balance (24,360 shares). Old name, new name

Inferred rename: "Judith Glickman Lauder" is treated as the same holder as "Spouse of LAL", because the old name was never reported again and the new one opened with the same balance (10,000 shares). Old name, new name

Inferred rename: "Jane A. Lauder 2003 Revocable Trust" is treated as the same holder as "Jane A. Lauder 2003 Trust", because the old name was never reported again and the new one opened with the same balance (17,161,020 shares). Old name, new name

Inferred rename: "Trustee" is treated as the same holder as "Through a grantor retained annuity trust", because the old name was never reported again and the new one opened with the same balance (12,000 shares). Old name, new name

Inferred rename: "Through a grantor retained annuity trust established February 2020" is treated as the same holder as "Through a Grantor Retaned Annuity Trust", because the old name was never reported again and the new one opened with the same balance (15,000 shares). Old name, new name

Inferred rename: "Through a grantor retained annuity trust" is treated as the same holder as "Through a grantor retained annuity trust established in May 2020", because the old name was never reported again and the new one opened with the same balance (14,655 shares). Old name, new name

Inferred typo: the share class "Class A Common Strock" is treated as the same class as "Class A Common Stock" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Ronald Lauder, 2,026,338 shares): old title, new title

Inferred typo: the share class "Class A Comon Stock" is treated as the same class as "Class A Common Stock" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Sara Moss, 41,098 shares): old title, new title

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology3,117 filings from SEC EDGAR, and how we read them

All 3,117 Forms 3, 4 and 5 filed for Estée Lauder (SEC CIK 1001250) from Jun 7, 1996 to Sep 16, 2026, retrieved from SEC EDGAR on Oct 8, 2026. Prices are the ones reported in each filing, often weighted averages. 380 older filings exist only on paper and could not be read.

Probable 2-for-1 stock split on or before Jan 20, 2012 (split date stated in a footnote). Splits aren't reported as transactions; 24 holding lines changed by exactly this ratio, so earlier share counts are restated.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (32)No filing in 18 months; last reported balances, not in any total
NameLast filedLast reported balance
Richard ParsonsNov 12, 20243,042 shares, last reported balance as of Nov 30, 2021
Fabrizio FredaNov 5, 2024295,838 shares, last reported balance as of Nov 1, 2024
Carl HaneyNov 5, 202411,847 shares, last reported balance as of Nov 1, 2024
Michael O'HareNov 5, 20249,540 shares, last reported balance as of Nov 1, 2024
Peter JueptnerNov 5, 20247,354 shares, last reported balance as of Nov 1, 2024
Tracey TravisAug 29, 202447,248 shares, last reported balance as of May 15, 2024
Deirdre StanleyFeb 7, 202413,025 shares, last reported balance as of Feb 7, 2024
Wei ChristiansonSep 18, 202314,215 shares, last reported balance as of May 16, 2023
Sara MossJun 1, 2023224,716 shares, last reported balance as of May 31, 2023
Rose BravoSep 16, 2022No balance on record
John DemseyFeb 10, 20226,607 shares, last reported balance as of Feb 9, 2022
Cedric ProuveNov 2, 2021181,288 shares, last reported balance as of Nov 1, 2021
Irvine Hockaday Jr.Sep 16, 2021No balance on record
LAUDER RONALD S FOUNDATIONMar 3, 202166,971 shares, last reported balance as of Mar 3, 2021
Gregory PolcerNov 9, 202079,314 shares, last reported balance as of Nov 9, 2020
Alexandra TrowerNov 4, 202020,405 shares, last reported balance as of Nov 4, 2020
Mellody HobsonSep 18, 2018169,223 shares, last reported balance as of Aug 29, 2017
Amy DiGesoSep 10, 201339,431 shares, last reported balance as of Sep 4, 2013
Richard KunesMay 8, 201256 shares, last reported balance as of May 7, 2012
Harvey GedeonNov 2, 201145,682 shares, last reported balance as of Oct 31, 2011
Carol BoulangerApr 19, 20108,000 shares, last reported balance as of Apr 15, 2010
Daniel BrestleNov 4, 2008128,260 shares, last reported balance as of Oct 31, 2008
Malcolm BondSep 12, 200811,491 shares, last reported balance as of Sep 4, 2008
Chavanne BousquetJun 16, 20082,644 shares, last reported balance as of Jun 13, 2008
Philip ShearerNov 2, 20079,922 shares, last reported balance as of Oct 31, 2007
Sally SusmanNov 2, 20074,960 shares, last reported balance as of Oct 31, 2007
Roger CaracappaNov 2, 20072,142 shares, last reported balance as of Oct 31, 2007
Marshall RoseJul 20, 2006No balance on record
Andrew CavanaughFeb 2, 2005888 shares, last reported balance as of Feb 1, 2005
Ira WenderSep 2, 2004No balance on record
Edward StrawMay 28, 2004No balance on record
Fred LanghammerMay 7, 2004100 shares, last reported balance as of May 6, 2004